123 related articles for article (PubMed ID: 36807179)
21. Postoperative Treatment of Resectable Pancreatic Cancer With Positive Peritoneal Lavage Cytology: A Multicentre Retrospective Study.
Todaka A; Nara S; Motoi F; Morinaga S; Toshiyama R; Higuchi R; Konishi M; Shirakawa H; Tsumura H; Okuyama H; Nagano H; Shioji K; Sugimachi K; Asagi A; Mizuno N; Furuse J
Anticancer Res; 2022 Feb; 42(2):893-902. PubMed ID: 35093887
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of intraoperative peritoneal washing cytology for patients with potentially resectable pancreatic ductal adenocarcinoma.
Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Hoshi N; Hoshi S; Hirabayashi K; Ogata Y
Pancreatology; 2017; 17(1):109-114. PubMed ID: 27840175
[TBL] [Abstract][Full Text] [Related]
23. Locally advanced pancreatic cancer successfully treated by distal pancreatectomy with celiac axis resection (DP-CAR) after S-1 with radiation therapy followed by gemcitabine/nab-paclitaxel therapy: a case report.
Ariake K; Motoi F; Mizuma M; Murakami K; Takadate T; Ohtsuka H; Fukase K; Masuda K; Hayashi H; Nakagawa K; Sakata N; Morikawa T; Maeda S; Naitoh T; Egawa S; Unno M
Surg Case Rep; 2017 Dec; 3(1):15. PubMed ID: 28101795
[TBL] [Abstract][Full Text] [Related]
24. [Treatment Experience of Chemotherapy and Carbon-Ion Radiotherapy followed by Curative Conversion Surgery for Initially Locally Advanced Unresectable Pancreatic Cancer after Distal Gastrectomy].
Watanabe H; Sugawara S; Takahashi R; Ashitomi Y; Kawashiro S; Sato H; Nemoto K; Kono M; Futakuchi M; Motoi F
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1959-1961. PubMed ID: 38303264
[TBL] [Abstract][Full Text] [Related]
25. Value of peritoneal cytology in potentially resectable pancreatic cancer.
Yamada S; Fujii T; Kanda M; Sugimoto H; Nomoto S; Takeda S; Nakao A; Kodera Y
Br J Surg; 2013 Dec; 100(13):1791-6. PubMed ID: 24227366
[TBL] [Abstract][Full Text] [Related]
26. Subclinical cancer cell dissemination in peritoneal lavage fluid detected by reverse-transcription polymerase chain reaction identifies patients at high risk for peritoneal recurrence and consequent impaired survival in the setting of preoperative chemoradiation therapy for pancreatic cancer.
Takahashi H; Akita H; Wada H; Tomokuni A; Asukai K; Takahashi Y; Yanagimoto Y; Matsunaga T; Sugimura K; Yamamoto K; Nishimura J; Yasui M; Omori T; Miyata H; Yamamoto T; Nakanishi M; Shirayanagi M; Yamasaki T; Ohue M; Yano M; Sakon M; Ishikawa O
Surgery; 2018 Dec; 164(6):1168-1177. PubMed ID: 30146098
[TBL] [Abstract][Full Text] [Related]
27. [A case of radical resection for pancreatic head cancer with peritoneal dissemination treated with combination chemotherapy].
Nakajima T; Tsukamoto T; Kanazawa A; Shimizu S; Sakae M; Ohira G; Yoshii M; Ishikawa A; Mori Y; Kotsuka M; Goto W; Kurihara S; Tashima T; Deguchi S; Tachimori A; Tamamori Y; Yamamoto A; Inoue T; Yamashita Y; Nishiguchi Y
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2181-3. PubMed ID: 25731463
[TBL] [Abstract][Full Text] [Related]
28. [R0 Resection of Locally Advanced Pancreatic Cancer after Combination Chemotherapy with Gemcitabine and S-1].
Kametaka H; Makino H; Fukada T; Seike K; Koyama T; Hasegawa A
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1641-3. PubMed ID: 26805123
[TBL] [Abstract][Full Text] [Related]
29. Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial.
Kunzmann V; Siveke JT; Algül H; Goekkurt E; Siegler G; Martens U; Waldschmidt D; Pelzer U; Fuchs M; Kullmann F; Boeck S; Ettrich TJ; Held S; Keller R; Klein I; Germer CT; Stein H; Friess H; Bahra M; Jakobs R; Hartlapp I; Heinemann V;
Lancet Gastroenterol Hepatol; 2021 Feb; 6(2):128-138. PubMed ID: 33338442
[TBL] [Abstract][Full Text] [Related]
30. [Laparoscopic Liver Resection for Liver Metastasis from Unresectable Pancreatic Ductal Adenocarcinoma Well-Controlled by Chemotherapy-A Case Report].
Nobori C; Tsukamoto T; Nishiyama T; Kunimoto T; Kaizaki R; Inoue T; Nishiguchi Y
Gan To Kagaku Ryoho; 2020 Dec; 47(13):1881-1883. PubMed ID: 33468860
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Impact of Positive Peritoneal Lavage Cytology on Resectable Pancreatic Body and Tail Cancer: A Retrospective Study.
Mashiko T; Ogasawara T; Masuoka Y; Ei S; Takahashi S; Hirabayashi K; Mori M; Koyanagi K; Yamamoto S; Nakagohri T
World J Surg; 2023 Mar; 47(3):729-739. PubMed ID: 36357802
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for peritoneal dissemination of gastric cancer.
Yeldan E; Oguz S; Usta U; Ilhan E; Senlikci A
Minerva Chir; 2015 Apr; 70(2):91-6. PubMed ID: 25815699
[TBL] [Abstract][Full Text] [Related]
33. [Application of laparoscopic exploration combined with abdominal exfoliative cytology in the diagnosis and treatment of locally advanced gastric cancer].
Ding PA; Liu Y; Guo HH; Yang PG; Tian Y; Fan LQ; Tan BB; Li Y; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):170-176. PubMed ID: 32074798
[No Abstract] [Full Text] [Related]
34. Postoperative cytology for drained fluid from the pancreatic bed after "curative" resection of pancreatic cancers: does it predict both the patient's prognosis and the site of cancer recurrence?
Ishikawa O; Wada H; Ohigashi H; Doki Y; Yokoyama S; Noura S; Yamada T; Sasaki Y; Imaoka S; Kasugai T; Matsunaga T; Takenaka A; Nakaizumi A
Ann Surg; 2003 Jul; 238(1):103-10. PubMed ID: 12832972
[TBL] [Abstract][Full Text] [Related]
35. [A case of pancreatic cancer with distant metastasis successfully resected after neoadjuvant chemotherapy with a combination of S-1 and gemcitabine].
Maeda T; Tsuchiya M; Ishii J; Koda T; Kubota Y; Katagiri T; Tamura A; Otsuka Y; Shibuya K; Kaneko H
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2184-6. PubMed ID: 25731464
[TBL] [Abstract][Full Text] [Related]
36. Evaluating staging laparoscopy indications for pancreatic cancer based on resectability classification and treatment strategies for patients with positive peritoneal washing cytology.
Igarashi T; Fukasawa M; Watanabe T; Kimura N; Itoh A; Tanaka H; Shibuya K; Yoshioka I; Hirabayashi K; Fujii T
Ann Gastroenterol Surg; 2024 Jan; 8(1):124-132. PubMed ID: 38250680
[TBL] [Abstract][Full Text] [Related]
37. Role of Conversion Surgery for Unresectable Pancreatic Cancer After Long-Term Chemotherapy.
Tsuchiya N; Matsuyama R; Murakami T; Yabushita Y; Sawada Y; Kumamoto T; Endo I
World J Surg; 2020 Aug; 44(8):2752-2760. PubMed ID: 32291503
[TBL] [Abstract][Full Text] [Related]
38. Preoperative treatment with gemcitabine plus nab-paclitaxel is a safe and effective chemotherapy for pancreatic adenocarcinoma.
Ielpo B; Duran H; Diaz E; Fabra I; Caruso R; Ferri V; Malavé L; Hidalgo M; Alvarez R; Plaza C; Quijano Y; Vicente E
Eur J Surg Oncol; 2016 Sep; 42(9):1394-400. PubMed ID: 26899943
[TBL] [Abstract][Full Text] [Related]
39. Conversion therapy for pancreatic cancer with peritoneal metastases using intravenous and intraperitoneal paclitaxel with S-1.
Kitayama H; Tsuji Y; Kondo T; Sugiyama J; Hirayama M; Yamamoto K; Kawarada Y; Oyamada Y; Hirano S
Mol Clin Oncol; 2016 Dec; 5(6):779-782. PubMed ID: 28105356
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for latent distant organ metastasis detected by staging laparoscopy in patients with radiologically defined locally advanced pancreatic ductal adenocarcinoma.
Karabicak I; Satoi S; Yanagimoto H; Yamamoto T; Hirooka S; Yamaki S; Kosaka H; Inoue K; Matsui Y; Kon M
J Hepatobiliary Pancreat Sci; 2016 Dec; 23(12):750-755. PubMed ID: 27794194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
